Steven Keith Burke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven keith burke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Keith Burke Today - Breaking & Trending Today

Insider Selling: Akebia Therapeutics, Inc. (NASDAQ:AKBA) SVP Sells 24,311 Shares of Stock

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Free Report) SVP Steven Keith Burke sold 24,311 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $1.68, for a total transaction of $40,842.48. Following the completion of the sale, the senior vice president now owns 711,376 […] ....

Steven Keith Burke , Akebia Therapeutics Inc , Mirabella Financial Services , Archer Investment Corp , Mackenzie Financial Corp , Raymond James Associates , Akebia Therapeutics , Get Free Report , Keith Burke , Therapeutics Trading Down , Investment Corp , Financial Corp , Akebia Therapeutics Daily , Nasdaq Akba , Insider Trading , Nsider Trades ,

Akebia Therapeutics, Inc. (NASDAQ:AKBA) SVP Steven Keith Burke Sells 24,311 Shares

Akebia Therapeutics, Inc. (NASDAQ:AKBA) SVP Steven Keith Burke Sells 24,311 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Steven Keith Burke , Mackenzie Financial Corp , Archer Investment Corp , Akebia Therapeutics Inc , Sapient Capital , Akebia Therapeutics Company Profile , Citigroup Inc , Raymond James Associates , Akebia Therapeutics , Get Free Report , Keith Burke , Therapeutics Trading Down , Investment Corp , Financial Corp , Akebia Therapeutics Daily ,

Akebia Therapeutics (NASDAQ:AKBA) Given "Neutral" Rating at HC Wainwright

Akebia Therapeutics (NASDAQ:AKBA) Given "Neutral" Rating at HC Wainwright
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Piper Sandler , Nicoler Hadas , Steven Keith Burke , Swiss National Bank , Akebia Therapeutics Company Profile , Akebia Therapeutics Inc , Eudaimonia Partners , Hightower Advisors , Asset Management Group , Akebia Therapeutics , Get Free Report , Therapeutics Trading Down , Keith Burke , Tower Advisors , Management Group , National Bank , Akebia Therapeutics Daily ,

Akebia Therapeutics (NASDAQ:AKBA) Share Price Crosses Above Fifty Day Moving Average of $0.95

Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Rating) shares passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.95 and traded as high as $1.28. Akebia Therapeutics shares last traded at $1.23, with a volume of 1,657,800 shares. Analyst Ratings Changes AKBA has been the subject […] ....

Piper Sandler , Nicoler Hadas , Steven Keith Burke , Akebia Therapeutics Company Profile , Mirabella Financial Services , Jpmorgan Chase Co , Akebia Therapeutics Inc , Hightower Advisors , Securities Exchange Commission , Akebia Therapeutics , Get Rating , Exchange Commission , Keith Burke , Financial Services , Tower Advisors , Akebia Therapeutics Daily , Nasdaq Akba ,

Akebia Therapeutics (NASDAQ:AKBA) Upgraded by Piper Sandler to Overweight

Piper Sandler upgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Get Rating) from a neutral rating to an overweight rating in a research note released on Wednesday, The Fly reports. A number of other brokerages have also issued reports on AKBA. StockNews.com lowered Akebia Therapeutics from a buy rating to a hold rating in a research […] ....

Michel Dahan , Steven Keith Burke , Piper Sandler , Metlife Investment Management , Hightower Advisors , Securities Exchange Commission , Jpmorgan Chase Co , Akebia Therapeutics Inc , Akebia Therapeutics Company Profile , Mirabella Financial Services , Icon Wealth Partners , Akebia Therapeutics , Get Rating , Keith Burke , Exchange Commission , Wealth Partners , Financial Services , Tower Advisors , Life Investment Management , Akebia Therapeutics Daily , Nasdaq Akba ,